Global Companion Diagnostic Tests in Oncology Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Companion Diagnostic Tests in Oncology market size was valued at US$ 3814.3 million in 2023. With growing demand in downstream market, the Companion Diagnostic Tests in Oncology is forecast to a readjusted size of US$ 7364.7 million by 2030 with a CAGR of 9.9% during review period.
The research report highlights the growth potential of the global Companion Diagnostic Tests in Oncology market. Companion Diagnostic Tests in Oncology are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Companion Diagnostic Tests in Oncology. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Companion Diagnostic Tests in Oncology market.
Increasing incidence of cancer, rising cost burden of cancer treatment, and increasing mortalities due to cancer, are some of the major reasons for increasing demand for new and technologically advanced treatment options, therapies, and drugs for the treatment of cancer.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Companion Diagnostic Tests in Oncology market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Companion Diagnostic Tests in Oncology market. It may include historical data, market segmentation by Type (e.g., Protein Detection, DNA Detection), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Companion Diagnostic Tests in Oncology market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Companion Diagnostic Tests in Oncology market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Companion Diagnostic Tests in Oncology industry. This include advancements in Companion Diagnostic Tests in Oncology technology, Companion Diagnostic Tests in Oncology new entrants, Companion Diagnostic Tests in Oncology new investment, and other innovations that are shaping the future of Companion Diagnostic Tests in Oncology.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Companion Diagnostic Tests in Oncology market. It includes factors influencing customer ' purchasing decisions, preferences for Companion Diagnostic Tests in Oncology product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Companion Diagnostic Tests in Oncology market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Companion Diagnostic Tests in Oncology market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Companion Diagnostic Tests in Oncology market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Companion Diagnostic Tests in Oncology industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Companion Diagnostic Tests in Oncology market.
Market Segmentation:
Companion Diagnostic Tests in Oncology market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Companion Diagnostic Tests in Oncology market size was valued at US$ 3814.3 million in 2023. With growing demand in downstream market, the Companion Diagnostic Tests in Oncology is forecast to a readjusted size of US$ 7364.7 million by 2030 with a CAGR of 9.9% during review period.
The research report highlights the growth potential of the global Companion Diagnostic Tests in Oncology market. Companion Diagnostic Tests in Oncology are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Companion Diagnostic Tests in Oncology. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Companion Diagnostic Tests in Oncology market.
Increasing incidence of cancer, rising cost burden of cancer treatment, and increasing mortalities due to cancer, are some of the major reasons for increasing demand for new and technologically advanced treatment options, therapies, and drugs for the treatment of cancer.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Companion Diagnostic Tests in Oncology market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Companion Diagnostic Tests in Oncology market. It may include historical data, market segmentation by Type (e.g., Protein Detection, DNA Detection), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Companion Diagnostic Tests in Oncology market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Companion Diagnostic Tests in Oncology market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Companion Diagnostic Tests in Oncology industry. This include advancements in Companion Diagnostic Tests in Oncology technology, Companion Diagnostic Tests in Oncology new entrants, Companion Diagnostic Tests in Oncology new investment, and other innovations that are shaping the future of Companion Diagnostic Tests in Oncology.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Companion Diagnostic Tests in Oncology market. It includes factors influencing customer ' purchasing decisions, preferences for Companion Diagnostic Tests in Oncology product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Companion Diagnostic Tests in Oncology market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Companion Diagnostic Tests in Oncology market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Companion Diagnostic Tests in Oncology market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Companion Diagnostic Tests in Oncology industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Companion Diagnostic Tests in Oncology market.
Market Segmentation:
Companion Diagnostic Tests in Oncology market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Protein Detection
- DNA Detection
- Pharmaceutical & Biotechnology Companies
- Medical Device Companies
- Research Institutes
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott
- Roche
- Genomic Health
- QIAGEN
- Agilent
- Agendia
- BioMerieux
- Illumina
- Siemens Healthcare
- Thermo Fisher
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Companion Diagnostic Tests in Oncology Market Size 2019-2030
2.1.2 Companion Diagnostic Tests in Oncology Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Companion Diagnostic Tests in Oncology Segment by Type
2.2.1 Protein Detection
2.2.2 DNA Detection
2.3 Companion Diagnostic Tests in Oncology Market Size by Type
2.3.1 Companion Diagnostic Tests in Oncology Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Companion Diagnostic Tests in Oncology Market Size Market Share by Type (2019-2024)
2.4 Companion Diagnostic Tests in Oncology Segment by Application
2.4.1 Pharmaceutical & Biotechnology Companies
2.4.2 Medical Device Companies
2.4.3 Research Institutes
2.4.4 Others
2.5 Companion Diagnostic Tests in Oncology Market Size by Application
2.5.1 Companion Diagnostic Tests in Oncology Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Companion Diagnostic Tests in Oncology Market Size Market Share by Application (2019-2024)
3 COMPANION DIAGNOSTIC TESTS IN ONCOLOGY MARKET SIZE BY PLAYER
3.1 Companion Diagnostic Tests in Oncology Market Size Market Share by Players
3.1.1 Global Companion Diagnostic Tests in Oncology Revenue by Players (2019-2024)
3.1.2 Global Companion Diagnostic Tests in Oncology Revenue Market Share by Players (2019-2024)
3.2 Global Companion Diagnostic Tests in Oncology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 COMPANION DIAGNOSTIC TESTS IN ONCOLOGY BY REGIONS
4.1 Companion Diagnostic Tests in Oncology Market Size by Regions (2019-2024)
4.2 Americas Companion Diagnostic Tests in Oncology Market Size Growth (2019-2024)
4.3 APAC Companion Diagnostic Tests in Oncology Market Size Growth (2019-2024)
4.4 Europe Companion Diagnostic Tests in Oncology Market Size Growth (2019-2024)
4.5 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Companion Diagnostic Tests in Oncology Market Size by Country (2019-2024)
5.2 Americas Companion Diagnostic Tests in Oncology Market Size by Type (2019-2024)
5.3 Americas Companion Diagnostic Tests in Oncology Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Companion Diagnostic Tests in Oncology Market Size by Region (2019-2024)
6.2 APAC Companion Diagnostic Tests in Oncology Market Size by Type (2019-2024)
6.3 APAC Companion Diagnostic Tests in Oncology Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Companion Diagnostic Tests in Oncology by Country (2019-2024)
7.2 Europe Companion Diagnostic Tests in Oncology Market Size by Type (2019-2024)
7.3 Europe Companion Diagnostic Tests in Oncology Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Companion Diagnostic Tests in Oncology by Region (2019-2024)
8.2 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Type (2019-2024)
8.3 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL COMPANION DIAGNOSTIC TESTS IN ONCOLOGY MARKET FORECAST
10.1 Global Companion Diagnostic Tests in Oncology Forecast by Regions (2025-2030)
10.1.1 Global Companion Diagnostic Tests in Oncology Forecast by Regions (2025-2030)
10.1.2 Americas Companion Diagnostic Tests in Oncology Forecast
10.1.3 APAC Companion Diagnostic Tests in Oncology Forecast
10.1.4 Europe Companion Diagnostic Tests in Oncology Forecast
10.1.5 Middle East & Africa Companion Diagnostic Tests in Oncology Forecast
10.2 Americas Companion Diagnostic Tests in Oncology Forecast by Country (2025-2030)
10.2.1 United States Companion Diagnostic Tests in Oncology Market Forecast
10.2.2 Canada Companion Diagnostic Tests in Oncology Market Forecast
10.2.3 Mexico Companion Diagnostic Tests in Oncology Market Forecast
10.2.4 Brazil Companion Diagnostic Tests in Oncology Market Forecast
10.3 APAC Companion Diagnostic Tests in Oncology Forecast by Region (2025-2030)
10.3.1 China Companion Diagnostic Tests in Oncology Market Forecast
10.3.2 Japan Companion Diagnostic Tests in Oncology Market Forecast
10.3.3 Korea Companion Diagnostic Tests in Oncology Market Forecast
10.3.4 Southeast Asia Companion Diagnostic Tests in Oncology Market Forecast
10.3.5 India Companion Diagnostic Tests in Oncology Market Forecast
10.3.6 Australia Companion Diagnostic Tests in Oncology Market Forecast
10.4 Europe Companion Diagnostic Tests in Oncology Forecast by Country (2025-2030)
10.4.1 Germany Companion Diagnostic Tests in Oncology Market Forecast
10.4.2 France Companion Diagnostic Tests in Oncology Market Forecast
10.4.3 UK Companion Diagnostic Tests in Oncology Market Forecast
10.4.4 Italy Companion Diagnostic Tests in Oncology Market Forecast
10.4.5 Russia Companion Diagnostic Tests in Oncology Market Forecast
10.5 Middle East & Africa Companion Diagnostic Tests in Oncology Forecast by Region (2025-2030)
10.5.1 Egypt Companion Diagnostic Tests in Oncology Market Forecast
10.5.2 South Africa Companion Diagnostic Tests in Oncology Market Forecast
10.5.3 Israel Companion Diagnostic Tests in Oncology Market Forecast
10.5.4 Turkey Companion Diagnostic Tests in Oncology Market Forecast
10.5.5 GCC Countries Companion Diagnostic Tests in Oncology Market Forecast
10.6 Global Companion Diagnostic Tests in Oncology Forecast by Type (2025-2030)
10.7 Global Companion Diagnostic Tests in Oncology Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Companion Diagnostic Tests in Oncology Product Offered
11.1.3 Abbott Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Companion Diagnostic Tests in Oncology Product Offered
11.2.3 Roche Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Genomic Health
11.3.1 Genomic Health Company Information
11.3.2 Genomic Health Companion Diagnostic Tests in Oncology Product Offered
11.3.3 Genomic Health Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Genomic Health Main Business Overview
11.3.5 Genomic Health Latest Developments
11.4 QIAGEN
11.4.1 QIAGEN Company Information
11.4.2 QIAGEN Companion Diagnostic Tests in Oncology Product Offered
11.4.3 QIAGEN Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 QIAGEN Main Business Overview
11.4.5 QIAGEN Latest Developments
11.5 Agilent
11.5.1 Agilent Company Information
11.5.2 Agilent Companion Diagnostic Tests in Oncology Product Offered
11.5.3 Agilent Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Agilent Main Business Overview
11.5.5 Agilent Latest Developments
11.6 Agendia
11.6.1 Agendia Company Information
11.6.2 Agendia Companion Diagnostic Tests in Oncology Product Offered
11.6.3 Agendia Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Agendia Main Business Overview
11.6.5 Agendia Latest Developments
11.7 BioMerieux
11.7.1 BioMerieux Company Information
11.7.2 BioMerieux Companion Diagnostic Tests in Oncology Product Offered
11.7.3 BioMerieux Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 BioMerieux Main Business Overview
11.7.5 BioMerieux Latest Developments
11.8 Illumina
11.8.1 Illumina Company Information
11.8.2 Illumina Companion Diagnostic Tests in Oncology Product Offered
11.8.3 Illumina Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Illumina Main Business Overview
11.8.5 Illumina Latest Developments
11.9 Siemens Healthcare
11.9.1 Siemens Healthcare Company Information
11.9.2 Siemens Healthcare Companion Diagnostic Tests in Oncology Product Offered
11.9.3 Siemens Healthcare Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Siemens Healthcare Main Business Overview
11.9.5 Siemens Healthcare Latest Developments
11.10 Thermo Fisher
11.10.1 Thermo Fisher Company Information
11.10.2 Thermo Fisher Companion Diagnostic Tests in Oncology Product Offered
11.10.3 Thermo Fisher Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Thermo Fisher Main Business Overview
11.10.5 Thermo Fisher Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Companion Diagnostic Tests in Oncology Market Size 2019-2030
2.1.2 Companion Diagnostic Tests in Oncology Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Companion Diagnostic Tests in Oncology Segment by Type
2.2.1 Protein Detection
2.2.2 DNA Detection
2.3 Companion Diagnostic Tests in Oncology Market Size by Type
2.3.1 Companion Diagnostic Tests in Oncology Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Companion Diagnostic Tests in Oncology Market Size Market Share by Type (2019-2024)
2.4 Companion Diagnostic Tests in Oncology Segment by Application
2.4.1 Pharmaceutical & Biotechnology Companies
2.4.2 Medical Device Companies
2.4.3 Research Institutes
2.4.4 Others
2.5 Companion Diagnostic Tests in Oncology Market Size by Application
2.5.1 Companion Diagnostic Tests in Oncology Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Companion Diagnostic Tests in Oncology Market Size Market Share by Application (2019-2024)
3 COMPANION DIAGNOSTIC TESTS IN ONCOLOGY MARKET SIZE BY PLAYER
3.1 Companion Diagnostic Tests in Oncology Market Size Market Share by Players
3.1.1 Global Companion Diagnostic Tests in Oncology Revenue by Players (2019-2024)
3.1.2 Global Companion Diagnostic Tests in Oncology Revenue Market Share by Players (2019-2024)
3.2 Global Companion Diagnostic Tests in Oncology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 COMPANION DIAGNOSTIC TESTS IN ONCOLOGY BY REGIONS
4.1 Companion Diagnostic Tests in Oncology Market Size by Regions (2019-2024)
4.2 Americas Companion Diagnostic Tests in Oncology Market Size Growth (2019-2024)
4.3 APAC Companion Diagnostic Tests in Oncology Market Size Growth (2019-2024)
4.4 Europe Companion Diagnostic Tests in Oncology Market Size Growth (2019-2024)
4.5 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Companion Diagnostic Tests in Oncology Market Size by Country (2019-2024)
5.2 Americas Companion Diagnostic Tests in Oncology Market Size by Type (2019-2024)
5.3 Americas Companion Diagnostic Tests in Oncology Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Companion Diagnostic Tests in Oncology Market Size by Region (2019-2024)
6.2 APAC Companion Diagnostic Tests in Oncology Market Size by Type (2019-2024)
6.3 APAC Companion Diagnostic Tests in Oncology Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Companion Diagnostic Tests in Oncology by Country (2019-2024)
7.2 Europe Companion Diagnostic Tests in Oncology Market Size by Type (2019-2024)
7.3 Europe Companion Diagnostic Tests in Oncology Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Companion Diagnostic Tests in Oncology by Region (2019-2024)
8.2 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Type (2019-2024)
8.3 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL COMPANION DIAGNOSTIC TESTS IN ONCOLOGY MARKET FORECAST
10.1 Global Companion Diagnostic Tests in Oncology Forecast by Regions (2025-2030)
10.1.1 Global Companion Diagnostic Tests in Oncology Forecast by Regions (2025-2030)
10.1.2 Americas Companion Diagnostic Tests in Oncology Forecast
10.1.3 APAC Companion Diagnostic Tests in Oncology Forecast
10.1.4 Europe Companion Diagnostic Tests in Oncology Forecast
10.1.5 Middle East & Africa Companion Diagnostic Tests in Oncology Forecast
10.2 Americas Companion Diagnostic Tests in Oncology Forecast by Country (2025-2030)
10.2.1 United States Companion Diagnostic Tests in Oncology Market Forecast
10.2.2 Canada Companion Diagnostic Tests in Oncology Market Forecast
10.2.3 Mexico Companion Diagnostic Tests in Oncology Market Forecast
10.2.4 Brazil Companion Diagnostic Tests in Oncology Market Forecast
10.3 APAC Companion Diagnostic Tests in Oncology Forecast by Region (2025-2030)
10.3.1 China Companion Diagnostic Tests in Oncology Market Forecast
10.3.2 Japan Companion Diagnostic Tests in Oncology Market Forecast
10.3.3 Korea Companion Diagnostic Tests in Oncology Market Forecast
10.3.4 Southeast Asia Companion Diagnostic Tests in Oncology Market Forecast
10.3.5 India Companion Diagnostic Tests in Oncology Market Forecast
10.3.6 Australia Companion Diagnostic Tests in Oncology Market Forecast
10.4 Europe Companion Diagnostic Tests in Oncology Forecast by Country (2025-2030)
10.4.1 Germany Companion Diagnostic Tests in Oncology Market Forecast
10.4.2 France Companion Diagnostic Tests in Oncology Market Forecast
10.4.3 UK Companion Diagnostic Tests in Oncology Market Forecast
10.4.4 Italy Companion Diagnostic Tests in Oncology Market Forecast
10.4.5 Russia Companion Diagnostic Tests in Oncology Market Forecast
10.5 Middle East & Africa Companion Diagnostic Tests in Oncology Forecast by Region (2025-2030)
10.5.1 Egypt Companion Diagnostic Tests in Oncology Market Forecast
10.5.2 South Africa Companion Diagnostic Tests in Oncology Market Forecast
10.5.3 Israel Companion Diagnostic Tests in Oncology Market Forecast
10.5.4 Turkey Companion Diagnostic Tests in Oncology Market Forecast
10.5.5 GCC Countries Companion Diagnostic Tests in Oncology Market Forecast
10.6 Global Companion Diagnostic Tests in Oncology Forecast by Type (2025-2030)
10.7 Global Companion Diagnostic Tests in Oncology Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Companion Diagnostic Tests in Oncology Product Offered
11.1.3 Abbott Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Companion Diagnostic Tests in Oncology Product Offered
11.2.3 Roche Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Genomic Health
11.3.1 Genomic Health Company Information
11.3.2 Genomic Health Companion Diagnostic Tests in Oncology Product Offered
11.3.3 Genomic Health Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Genomic Health Main Business Overview
11.3.5 Genomic Health Latest Developments
11.4 QIAGEN
11.4.1 QIAGEN Company Information
11.4.2 QIAGEN Companion Diagnostic Tests in Oncology Product Offered
11.4.3 QIAGEN Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 QIAGEN Main Business Overview
11.4.5 QIAGEN Latest Developments
11.5 Agilent
11.5.1 Agilent Company Information
11.5.2 Agilent Companion Diagnostic Tests in Oncology Product Offered
11.5.3 Agilent Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Agilent Main Business Overview
11.5.5 Agilent Latest Developments
11.6 Agendia
11.6.1 Agendia Company Information
11.6.2 Agendia Companion Diagnostic Tests in Oncology Product Offered
11.6.3 Agendia Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Agendia Main Business Overview
11.6.5 Agendia Latest Developments
11.7 BioMerieux
11.7.1 BioMerieux Company Information
11.7.2 BioMerieux Companion Diagnostic Tests in Oncology Product Offered
11.7.3 BioMerieux Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 BioMerieux Main Business Overview
11.7.5 BioMerieux Latest Developments
11.8 Illumina
11.8.1 Illumina Company Information
11.8.2 Illumina Companion Diagnostic Tests in Oncology Product Offered
11.8.3 Illumina Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Illumina Main Business Overview
11.8.5 Illumina Latest Developments
11.9 Siemens Healthcare
11.9.1 Siemens Healthcare Company Information
11.9.2 Siemens Healthcare Companion Diagnostic Tests in Oncology Product Offered
11.9.3 Siemens Healthcare Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Siemens Healthcare Main Business Overview
11.9.5 Siemens Healthcare Latest Developments
11.10 Thermo Fisher
11.10.1 Thermo Fisher Company Information
11.10.2 Thermo Fisher Companion Diagnostic Tests in Oncology Product Offered
11.10.3 Thermo Fisher Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Thermo Fisher Main Business Overview
11.10.5 Thermo Fisher Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Companion Diagnostic Tests in Oncology Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Protein Detection
Table 3. Major Players of DNA Detection
Table 4. Companion Diagnostic Tests in Oncology Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Companion Diagnostic Tests in Oncology Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Companion Diagnostic Tests in Oncology Market Size Market Share by Type (2019-2024)
Table 7. Companion Diagnostic Tests in Oncology Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Companion Diagnostic Tests in Oncology Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Companion Diagnostic Tests in Oncology Market Size Market Share by Application (2019-2024)
Table 10. Global Companion Diagnostic Tests in Oncology Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Player (2019-2024)
Table 12. Companion Diagnostic Tests in Oncology Key Players Head office and Products Offered
Table 13. Companion Diagnostic Tests in Oncology Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Companion Diagnostic Tests in Oncology Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Companion Diagnostic Tests in Oncology Market Size Market Share by Regions (2019-2024)
Table 18. Global Companion Diagnostic Tests in Oncology Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Companion Diagnostic Tests in Oncology Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Companion Diagnostic Tests in Oncology Market Size Market Share by Country (2019-2024)
Table 22. Americas Companion Diagnostic Tests in Oncology Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Companion Diagnostic Tests in Oncology Market Size Market Share by Type (2019-2024)
Table 24. Americas Companion Diagnostic Tests in Oncology Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Companion Diagnostic Tests in Oncology Market Size Market Share by Application (2019-2024)
Table 26. APAC Companion Diagnostic Tests in Oncology Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Companion Diagnostic Tests in Oncology Market Size Market Share by Region (2019-2024)
Table 28. APAC Companion Diagnostic Tests in Oncology Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Companion Diagnostic Tests in Oncology Market Size Market Share by Type (2019-2024)
Table 30. APAC Companion Diagnostic Tests in Oncology Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Companion Diagnostic Tests in Oncology Market Size Market Share by Application (2019-2024)
Table 32. Europe Companion Diagnostic Tests in Oncology Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Companion Diagnostic Tests in Oncology Market Size Market Share by Country (2019-2024)
Table 34. Europe Companion Diagnostic Tests in Oncology Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Companion Diagnostic Tests in Oncology Market Size Market Share by Type (2019-2024)
Table 36. Europe Companion Diagnostic Tests in Oncology Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Companion Diagnostic Tests in Oncology Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Companion Diagnostic Tests in Oncology
Table 45. Key Market Challenges & Risks of Companion Diagnostic Tests in Oncology
Table 46. Key Industry Trends of Companion Diagnostic Tests in Oncology
Table 47. Global Companion Diagnostic Tests in Oncology Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Companion Diagnostic Tests in Oncology Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Companion Diagnostic Tests in Oncology Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Companion Diagnostic Tests in Oncology Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Abbott Details, Company Type, Companion Diagnostic Tests in Oncology Area Served and Its Competitors
Table 52. Abbott Companion Diagnostic Tests in Oncology Product Offered
Table 53. Abbott Companion Diagnostic Tests in Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Abbott Main Business
Table 55. Abbott Latest Developments
Table 56. Roche Details, Company Type, Companion Diagnostic Tests in Oncology Area Served and Its Competitors
Table 57. Roche Companion Diagnostic Tests in Oncology Product Offered
Table 58. Roche Main Business
Table 59. Roche Companion Diagnostic Tests in Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Roche Latest Developments
Table 61. Genomic Health Details, Company Type, Companion Diagnostic Tests in Oncology Area Served and Its Competitors
Table 62. Genomic Health Companion Diagnostic Tests in Oncology Product Offered
Table 63. Genomic Health Main Business
Table 64. Genomic Health Companion Diagnostic Tests in Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Genomic Health Latest Developments
Table 66. QIAGEN Details, Company Type, Companion Diagnostic Tests in Oncology Area Served and Its Competitors
Table 67. QIAGEN Companion Diagnostic Tests in Oncology Product Offered
Table 68. QIAGEN Main Business
Table 69. QIAGEN Companion Diagnostic Tests in Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. QIAGEN Latest Developments
Table 71. Agilent Details, Company Type, Companion Diagnostic Tests in Oncology Area Served and Its Competitors
Table 72. Agilent Companion Diagnostic Tests in Oncology Product Offered
Table 73. Agilent Main Business
Table 74. Agilent Companion Diagnostic Tests in Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Agilent Latest Developments
Table 76. Agendia Details, Company Type, Companion Diagnostic Tests in Oncology Area Served and Its Competitors
Table 77. Agendia Companion Diagnostic Tests in Oncology Product Offered
Table 78. Agendia Main Business
Table 79. Agendia Companion Diagnostic Tests in Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Agendia Latest Developments
Table 81. BioMerieux Details, Company Type, Companion Diagnostic Tests in Oncology Area Served and Its Competitors
Table 82. BioMerieux Companion Diagnostic Tests in Oncology Product Offered
Table 83. BioMerieux Main Business
Table 84. BioMerieux Companion Diagnostic Tests in Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. BioMerieux Latest Developments
Table 86. Illumina Details, Company Type, Companion Diagnostic Tests in Oncology Area Served and Its Competitors
Table 87. Illumina Companion Diagnostic Tests in Oncology Product Offered
Table 88. Illumina Main Business
Table 89. Illumina Companion Diagnostic Tests in Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Illumina Latest Developments
Table 91. Siemens Healthcare Details, Company Type, Companion Diagnostic Tests in Oncology Area Served and Its Competitors
Table 92. Siemens Healthcare Companion Diagnostic Tests in Oncology Product Offered
Table 93. Siemens Healthcare Main Business
Table 94. Siemens Healthcare Companion Diagnostic Tests in Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Siemens Healthcare Latest Developments
Table 96. Thermo Fisher Details, Company Type, Companion Diagnostic Tests in Oncology Area Served and Its Competitors
Table 97. Thermo Fisher Companion Diagnostic Tests in Oncology Product Offered
Table 98. Thermo Fisher Main Business
Table 99. Thermo Fisher Companion Diagnostic Tests in Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Thermo Fisher Latest Developments
Table 1. Companion Diagnostic Tests in Oncology Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Protein Detection
Table 3. Major Players of DNA Detection
Table 4. Companion Diagnostic Tests in Oncology Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Companion Diagnostic Tests in Oncology Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Companion Diagnostic Tests in Oncology Market Size Market Share by Type (2019-2024)
Table 7. Companion Diagnostic Tests in Oncology Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Companion Diagnostic Tests in Oncology Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Companion Diagnostic Tests in Oncology Market Size Market Share by Application (2019-2024)
Table 10. Global Companion Diagnostic Tests in Oncology Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Player (2019-2024)
Table 12. Companion Diagnostic Tests in Oncology Key Players Head office and Products Offered
Table 13. Companion Diagnostic Tests in Oncology Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Companion Diagnostic Tests in Oncology Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Companion Diagnostic Tests in Oncology Market Size Market Share by Regions (2019-2024)
Table 18. Global Companion Diagnostic Tests in Oncology Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Companion Diagnostic Tests in Oncology Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Companion Diagnostic Tests in Oncology Market Size Market Share by Country (2019-2024)
Table 22. Americas Companion Diagnostic Tests in Oncology Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Companion Diagnostic Tests in Oncology Market Size Market Share by Type (2019-2024)
Table 24. Americas Companion Diagnostic Tests in Oncology Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Companion Diagnostic Tests in Oncology Market Size Market Share by Application (2019-2024)
Table 26. APAC Companion Diagnostic Tests in Oncology Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Companion Diagnostic Tests in Oncology Market Size Market Share by Region (2019-2024)
Table 28. APAC Companion Diagnostic Tests in Oncology Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Companion Diagnostic Tests in Oncology Market Size Market Share by Type (2019-2024)
Table 30. APAC Companion Diagnostic Tests in Oncology Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Companion Diagnostic Tests in Oncology Market Size Market Share by Application (2019-2024)
Table 32. Europe Companion Diagnostic Tests in Oncology Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Companion Diagnostic Tests in Oncology Market Size Market Share by Country (2019-2024)
Table 34. Europe Companion Diagnostic Tests in Oncology Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Companion Diagnostic Tests in Oncology Market Size Market Share by Type (2019-2024)
Table 36. Europe Companion Diagnostic Tests in Oncology Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Companion Diagnostic Tests in Oncology Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Companion Diagnostic Tests in Oncology
Table 45. Key Market Challenges & Risks of Companion Diagnostic Tests in Oncology
Table 46. Key Industry Trends of Companion Diagnostic Tests in Oncology
Table 47. Global Companion Diagnostic Tests in Oncology Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Companion Diagnostic Tests in Oncology Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Companion Diagnostic Tests in Oncology Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Companion Diagnostic Tests in Oncology Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Abbott Details, Company Type, Companion Diagnostic Tests in Oncology Area Served and Its Competitors
Table 52. Abbott Companion Diagnostic Tests in Oncology Product Offered
Table 53. Abbott Companion Diagnostic Tests in Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Abbott Main Business
Table 55. Abbott Latest Developments
Table 56. Roche Details, Company Type, Companion Diagnostic Tests in Oncology Area Served and Its Competitors
Table 57. Roche Companion Diagnostic Tests in Oncology Product Offered
Table 58. Roche Main Business
Table 59. Roche Companion Diagnostic Tests in Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Roche Latest Developments
Table 61. Genomic Health Details, Company Type, Companion Diagnostic Tests in Oncology Area Served and Its Competitors
Table 62. Genomic Health Companion Diagnostic Tests in Oncology Product Offered
Table 63. Genomic Health Main Business
Table 64. Genomic Health Companion Diagnostic Tests in Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Genomic Health Latest Developments
Table 66. QIAGEN Details, Company Type, Companion Diagnostic Tests in Oncology Area Served and Its Competitors
Table 67. QIAGEN Companion Diagnostic Tests in Oncology Product Offered
Table 68. QIAGEN Main Business
Table 69. QIAGEN Companion Diagnostic Tests in Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. QIAGEN Latest Developments
Table 71. Agilent Details, Company Type, Companion Diagnostic Tests in Oncology Area Served and Its Competitors
Table 72. Agilent Companion Diagnostic Tests in Oncology Product Offered
Table 73. Agilent Main Business
Table 74. Agilent Companion Diagnostic Tests in Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Agilent Latest Developments
Table 76. Agendia Details, Company Type, Companion Diagnostic Tests in Oncology Area Served and Its Competitors
Table 77. Agendia Companion Diagnostic Tests in Oncology Product Offered
Table 78. Agendia Main Business
Table 79. Agendia Companion Diagnostic Tests in Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Agendia Latest Developments
Table 81. BioMerieux Details, Company Type, Companion Diagnostic Tests in Oncology Area Served and Its Competitors
Table 82. BioMerieux Companion Diagnostic Tests in Oncology Product Offered
Table 83. BioMerieux Main Business
Table 84. BioMerieux Companion Diagnostic Tests in Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. BioMerieux Latest Developments
Table 86. Illumina Details, Company Type, Companion Diagnostic Tests in Oncology Area Served and Its Competitors
Table 87. Illumina Companion Diagnostic Tests in Oncology Product Offered
Table 88. Illumina Main Business
Table 89. Illumina Companion Diagnostic Tests in Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Illumina Latest Developments
Table 91. Siemens Healthcare Details, Company Type, Companion Diagnostic Tests in Oncology Area Served and Its Competitors
Table 92. Siemens Healthcare Companion Diagnostic Tests in Oncology Product Offered
Table 93. Siemens Healthcare Main Business
Table 94. Siemens Healthcare Companion Diagnostic Tests in Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Siemens Healthcare Latest Developments
Table 96. Thermo Fisher Details, Company Type, Companion Diagnostic Tests in Oncology Area Served and Its Competitors
Table 97. Thermo Fisher Companion Diagnostic Tests in Oncology Product Offered
Table 98. Thermo Fisher Main Business
Table 99. Thermo Fisher Companion Diagnostic Tests in Oncology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Thermo Fisher Latest Developments
LIST OF FIGURES
Figure 1. Companion Diagnostic Tests in Oncology Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Companion Diagnostic Tests in Oncology Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Companion Diagnostic Tests in Oncology Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Companion Diagnostic Tests in Oncology Sales Market Share by Country/Region (2023)
Figure 8. Companion Diagnostic Tests in Oncology Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Companion Diagnostic Tests in Oncology Market Size Market Share by Type in 2023
Figure 10. Companion Diagnostic Tests in Oncology in Pharmaceutical & Biotechnology Companies
Figure 11. Global Companion Diagnostic Tests in Oncology Market: Pharmaceutical & Biotechnology Companies (2019-2024) & ($ Millions)
Figure 12. Companion Diagnostic Tests in Oncology in Medical Device Companies
Figure 13. Global Companion Diagnostic Tests in Oncology Market: Medical Device Companies (2019-2024) & ($ Millions)
Figure 14. Companion Diagnostic Tests in Oncology in Research Institutes
Figure 15. Global Companion Diagnostic Tests in Oncology Market: Research Institutes (2019-2024) & ($ Millions)
Figure 16. Companion Diagnostic Tests in Oncology in Others
Figure 17. Global Companion Diagnostic Tests in Oncology Market: Others (2019-2024) & ($ Millions)
Figure 18. Global Companion Diagnostic Tests in Oncology Market Size Market Share by Application in 2023
Figure 19. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Player in 2023
Figure 20. Global Companion Diagnostic Tests in Oncology Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Companion Diagnostic Tests in Oncology Market Size 2019-2024 ($ Millions)
Figure 22. APAC Companion Diagnostic Tests in Oncology Market Size 2019-2024 ($ Millions)
Figure 23. Europe Companion Diagnostic Tests in Oncology Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size 2019-2024 ($ Millions)
Figure 25. Americas Companion Diagnostic Tests in Oncology Value Market Share by Country in 2023
Figure 26. United States Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Companion Diagnostic Tests in Oncology Market Size Market Share by Region in 2023
Figure 31. APAC Companion Diagnostic Tests in Oncology Market Size Market Share by Type in 2023
Figure 32. APAC Companion Diagnostic Tests in Oncology Market Size Market Share by Application in 2023
Figure 33. China Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Companion Diagnostic Tests in Oncology Market Size Market Share by Country in 2023
Figure 40. Europe Companion Diagnostic Tests in Oncology Market Size Market Share by Type (2019-2024)
Figure 41. Europe Companion Diagnostic Tests in Oncology Market Size Market Share by Application (2019-2024)
Figure 42. Germany Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 56. APAC Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 57. Europe Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 59. United States Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 60. Canada Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 63. China Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 64. Japan Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 65. Korea Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 67. India Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 68. Australia Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 69. Germany Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 70. France Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 71. UK Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 72. Italy Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 73. Russia Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 74. Spain Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 77. Israel Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 80. Global Companion Diagnostic Tests in Oncology Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Companion Diagnostic Tests in Oncology Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Companion Diagnostic Tests in Oncology Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Companion Diagnostic Tests in Oncology Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Companion Diagnostic Tests in Oncology Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Companion Diagnostic Tests in Oncology Sales Market Share by Country/Region (2023)
Figure 8. Companion Diagnostic Tests in Oncology Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Companion Diagnostic Tests in Oncology Market Size Market Share by Type in 2023
Figure 10. Companion Diagnostic Tests in Oncology in Pharmaceutical & Biotechnology Companies
Figure 11. Global Companion Diagnostic Tests in Oncology Market: Pharmaceutical & Biotechnology Companies (2019-2024) & ($ Millions)
Figure 12. Companion Diagnostic Tests in Oncology in Medical Device Companies
Figure 13. Global Companion Diagnostic Tests in Oncology Market: Medical Device Companies (2019-2024) & ($ Millions)
Figure 14. Companion Diagnostic Tests in Oncology in Research Institutes
Figure 15. Global Companion Diagnostic Tests in Oncology Market: Research Institutes (2019-2024) & ($ Millions)
Figure 16. Companion Diagnostic Tests in Oncology in Others
Figure 17. Global Companion Diagnostic Tests in Oncology Market: Others (2019-2024) & ($ Millions)
Figure 18. Global Companion Diagnostic Tests in Oncology Market Size Market Share by Application in 2023
Figure 19. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Player in 2023
Figure 20. Global Companion Diagnostic Tests in Oncology Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Companion Diagnostic Tests in Oncology Market Size 2019-2024 ($ Millions)
Figure 22. APAC Companion Diagnostic Tests in Oncology Market Size 2019-2024 ($ Millions)
Figure 23. Europe Companion Diagnostic Tests in Oncology Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size 2019-2024 ($ Millions)
Figure 25. Americas Companion Diagnostic Tests in Oncology Value Market Share by Country in 2023
Figure 26. United States Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Companion Diagnostic Tests in Oncology Market Size Market Share by Region in 2023
Figure 31. APAC Companion Diagnostic Tests in Oncology Market Size Market Share by Type in 2023
Figure 32. APAC Companion Diagnostic Tests in Oncology Market Size Market Share by Application in 2023
Figure 33. China Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Companion Diagnostic Tests in Oncology Market Size Market Share by Country in 2023
Figure 40. Europe Companion Diagnostic Tests in Oncology Market Size Market Share by Type (2019-2024)
Figure 41. Europe Companion Diagnostic Tests in Oncology Market Size Market Share by Application (2019-2024)
Figure 42. Germany Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Companion Diagnostic Tests in Oncology Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 56. APAC Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 57. Europe Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 59. United States Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 60. Canada Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 63. China Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 64. Japan Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 65. Korea Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 67. India Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 68. Australia Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 69. Germany Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 70. France Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 71. UK Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 72. Italy Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 73. Russia Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 74. Spain Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 77. Israel Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Companion Diagnostic Tests in Oncology Market Size 2025-2030 ($ Millions)
Figure 80. Global Companion Diagnostic Tests in Oncology Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Companion Diagnostic Tests in Oncology Market Size Market Share Forecast by Application (2025-2030)
